4//SEC Filing
COLA MICHAEL F 4
Accession 0001878894-21-000003
CIK 0001534120other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:28 PM ET
Size
5.5 KB
Accession
0001878894-21-000003
Insider Transaction Report
Form 4
COLA MICHAEL F
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-10-01+78,116→ 78,116 totalExercise: $2.25From: 2021-10-01Exp: 2031-10-01→ Common Stock (78,116 underlying)
Footnotes (1)
- [F1]100% of this stock option will immediately vest on the date that it is granted. If employment is terminated prior to the end of the calendar quarter in which the option was granted, the number of shares underlying such stock option that reflects the percentage of calendar days remaining in such calendar quarter after such employment termination date shall be forfeited and deemed cancelled.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
Related Parties
1- filerCIK 0001188940
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 4:28 PM ET
- Size
- 5.5 KB